Holen Sie sich die Stockscreener-App
90.44
0.71%
-0.65
Schlusskurs vom Vortag:
$91.09
Offen:
$90
24-Stunden-Volumen:
559.98K
Relative Volume:
1.30
Marktkapitalisierung:
$2.96B
Einnahmen:
$2.32B
Nettoeinkommen (Verlust:
$82.93M
KGV:
35.89
EPS:
2.52
Netto-Cashflow:
$203.54M
1W Leistung:
-2.33%
1M Leistung:
-1.89%
6M Leistung:
-7.61%
1J Leistung:
-3.39%
1-Tages-Spanne:
$89.76
$90.90
1-Wochen-Bereich:
$89.76
$92.94
52-Wochen-Spanne:
$82.15
$98.95
Amedisys Inc Stock (AMED) Company Profile
Firmenname
Amedisys Inc
Sektor
Branche
Telefon
(225) 292-2031
Adresse
3854 AMERICAN WAY, BATON ROUGE, LA
Vergleichen Sie AMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
90.44 | 2.96B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
316.42 | 78.58B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.09 | 13.55B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
129.60 | 12.66B | 20.97B | 3.13B | 2.39B | 31.21 |
|
DVA
Davita Inc
|
142.40 | 12.49B | 12.67B | 827.68M | 1.42B | 9.27 |
|
UHS
Universal Health Services Inc
|
180.03 | 11.88B | 15.42B | 1.03B | 956.84M | 15.02 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-07 | Herabstufung | Truist | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-03-13 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-08-02 | Herabstufung | UBS | Neutral → Sell |
| 2022-06-29 | Eingeleitet | Stifel | Hold |
| 2022-06-21 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-01 | Hochstufung | UBS | Sell → Neutral |
| 2022-02-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-02-25 | Bestätigt | Credit Suisse | Outperform |
| 2022-02-25 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-25 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-02-25 | Bestätigt | Raymond James | Outperform |
| 2022-02-25 | Bestätigt | Truist | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-10 | Bestätigt | The Benchmark Company | Buy |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-08-20 | Fortgesetzt | Barclays | Overweight |
| 2020-07-30 | Bestätigt | The Benchmark Company | Buy |
| 2020-06-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-05-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-03-09 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-01-17 | Eingeleitet | Credit Suisse | Outperform |
| 2019-11-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2019-09-17 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-12-14 | Eingeleitet | Barclays | Equal Weight |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-10-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2018-07-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-03-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-11-08 | Bestätigt | Mizuho | Buy |
| 2017-11-02 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-08-21 | Eingeleitet | BofA/Merrill | Neutral |
Alle ansehen
Amedisys Inc Aktie (AMED) Neueste Nachrichten
Short Interest in Amedisys, Inc. (NASDAQ:AMED) Rises By 7.1% - MarketBeat
Amedisys ticks lower as DOJ trial to block UnitedHealth deal set for Oct. 27 or later - MSN
ABC Arbitrage SA Invests $2.52 Million in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
United Health-Amedisys trial in US DOJ challenge 'tentatively' set for Oct. 27 - mlex.com
AMED: 3 Up-and-Coming Healthcare Providers Enhancing Patient Care - StockNews.com
State of Alaska Department of Revenue Increases Stock Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Brokerages Set Amedisys, Inc. (NASDAQ:AMED) Target Price at $100.75 - MarketBeat
Amedisys' (AMED) "Equal Weight" Rating Reaffirmed at Stephens - MarketBeat
Amedisys (AMED) Projected to Post Earnings on Wednesday - MarketBeat
Amedisys Avoids Whistleblower's Bid to Revive Hospice Fraud Suit - Bloomberg Law
Amedisys (AMED) Earnings Expected to Grow: Should You Buy? - MSN
UnitedHealth rebuts Justice Department allegations in $3.3B Amedisys deal - MSN
UnitedHealth, Amedisys plan divesture of up to 128 locations - Modern Healthcare
Federal judge sets Feb. 20 scheduling conference for UnitedHealth, Amedisys - mlex.com
Death Care Services Global Industry Report 2025, with - GlobeNewswire
Calamos Advisors LLC Grows Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
UnitedHealth Group files answer to US DOJ complaint over Amedisys deal - MLex
UnitedHealth Group Withdraws Motion To Dismiss DOJ’s Amedisys Lawsuit - Hospice News
UnitedHealth drops motion to dismiss DOJ’s antitrust case in $3.3B Amedisys deal - Star Tribune
FY2026 EPS Estimates for Amedisys Lifted by Leerink Partnrs - MarketBeat
UnitedHealth Group, Amedisys drop motion to dismiss DOJ lawsuit - Modern Healthcare
UnitedHealth Drops Dismissal Bid in US Suit Over Amedisys Deal - Bloomberg Law
Hospice Services Market Projected To Witness Substantial Growth, 2025-2032: VITAS Healthcare, Amedisys, - EIN News
Job: RN HospiceHospice | Entry Level Jobs | Internships for Students - CollegeRecruiter.com
Amedisys FY2024 EPS Estimate Decreased by Leerink Partnrs - MarketBeat
AMEDAmedisys Inc Latest Stock News & Market Updates - StockTitan
Amedisys Honors 47 Employees With Annual Spirit of Excellence Award - The Manila Times
FY2026 EPS Estimates for Amedisys Raised by Leerink Partnrs - Defense World
FY2024 EPS Estimates for Amedisys Lowered by Leerink Partnrs - Defense World
Pacer Advisors Inc. Increases Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
UnitedHealth-Amedisys motion to dismiss should be denied, US DOJ, state AGs say - MLex
DOJ Calls UnitedHealth Dismissal Bid A Discovery 'End Run' - Law360
Post Acute Care Market May See a Big Move | Amedisys, Sun Healthcare, Gentiva - openPR
3 Stocks to Gain From Trump's Family Caregiver Tax Credits - Benzinga
Nisa Investment Advisors LLC Buys 180 Shares of Amedisys, Inc. (NASDAQ:AMED) - Defense World
Amedisys, Inc. to Host Earnings Call - ACCESS Newswire
SG Americas Securities LLC Has $5.11 Million Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Ballentine Partners LLC Makes New $334,000 Investment in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal - MSN
Oak Thistle LLC Purchases 3,440 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Finanzdaten der Amedisys Inc-Aktie (AMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):